GlobeNewswire4d agoneutral
Edesa Biotech to Present at Guggenheim Healthcare Innovation ConferenceNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.72d agoneutral
3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical CatalystsZacks Small Cap Research76d agoneutral
EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get UnderwaySimply Wall St.199d agobullish
Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock BuyingInsider Monkey202d agoneutral
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo TreatmentSimply Wall St.376d agoneutral
Favourable Signals For Edesa Biotech: Numerous Insiders Acquired Stock